Dengue Fever Infection Reported in California
A person in California has contracted dengue fever, marking the third case since 2023. The infected individual did not travel abroad, making this a locally acquired case. Although the prevalence of dengue in the US remains low, the country has experienced an upward trend in cases over the last few years. The resurgence of the virus reflects a global rise in dengue, especially in the Americas. “While the likelihood of widespread transmission is low at this time, we must remain vigilant and prevent further cases through public education and mosquito control efforts”, said Mantu David, Los Angeles County health officer.
Full Story: CIDRAP
Two Studies Demonstrate Safety and Effectiveness of Medication to Prevent RSV
Two new studies showed Nirsevimab to be safe and effective at preventing severe illness from respiratory syncytial virus (RSV) in children. Nirsevimabis, sold under brand name Beyfortus, is a monoclonal antibody designed to prevent severe disease from RSV infections. The Centers for Disease Control and Prevention (CDC) advises that babies younger than 8 months receive one dose of medication in advance of their first RSV season. Every year 58,000-80,000 Americans under 5 years old die every year.
Full Story: CIDRAP
